Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Plasma lipid mediator (LM) profiling identifies hyper- and hypo-activated groups of patients with ACLF and targeted 20% human albumin solution infusion recalibrates abnormalities, Journal of Hepatology, January 2017, Elsevier,
DOI: 10.1016/s0168-8278(17)31131-5.
You can read the full text:
Contributors
The following have contributed to this page